這項研究獲得加拿大衛生研究院(Canadian Institutes of Health Research)、加拿大幹細胞網路(Stem Cell Network of Canada)、溫哥華幹細胞技術(Stem Cell Technologies of Vancouver)、JDRF 以及麥克史密斯健康研究基金會(Michael Smith Foundation for Health Research)的支持。
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005). Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine, 352(24), 2477–2486. https://doi.org/10.1056/NEJMoa042973
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., … & Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. (2009). A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine, 361(14), 1339–1348. https://doi.org/10.1056/NEJMoa0902430
Diguisto, C., et al. (2022). A study of diabetic ketoacidosis in the pregnant population in the United Kingdom: Investigating the incidence, aetiology, management and outcomes. Diabetic Medicine, 39(4), e14743. https://doi.org/10.1111/dme.14743
Ogawa, M., Irahara, M., Kamegai, H., Kuwahara, A., Yoshida, M., & Saito, H. (2013). ISRN Obstetrics and Gynecology, 2013, 120735. https://doi.org/10.1155/2013/120735
World Health Organization. (2022). WHO recommendation on tocolytic therapy.
Ubom, A. E., Lamont, R. F., & FIGO Working Group. (2023). International Journal of Gynecology & Obstetrics, 163(S2), 40–50. https://doi.org/10.1002/ijgo.15113
Chronic Kidney Disease Satyanarayana R. Vaidya; Narothama R. Aeddula.
KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: A primer on what pharmacists need to know
Fernández-Fernandez B, Sarafidis P, Soler MJ, Ortiz A. EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors. Clin Kidney J. 2023 Jun 16;16(8):1187-1198. doi: 10.1093/ckj/sfad082. PMID: 37529652; PMCID: PMC10387399
Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach
如果生存開關的啟動只與熱量有關,無論是吃軟糖,還是喝汽水,高果糖玉米糖漿所產生的作用理當一樣。但事實並非如此,喝糖通常比吃糖更糟得多。為什麼會這樣?生存開關是由於肝臟中的 ATP 濃度下降所觸發,因此關鍵在於有多少果糖到達肝臟。如果肝臟接收到大量果糖,則 ATP 會大幅下降,刺激生存開關強烈反應。倘若只有少量果糖到達肝臟,果糖代謝效應會比較溫和。這意味著,儘管我們在談論生存開關時,一直將它簡化為一種按鈕,可控制為開或關,但實際狀況比較像是可調整強度的旋轉鈕,會根據狀況產生強弱不同的反應。